Evidence map›Paper›PMID 36765428›Full record

ArticleWorld journal of surgical oncology2023

Feasibility analysis of combined surgery for esophageal cancer.

Zhulin Wang, Shaowu Sun, Kaiyuan Li, Chunyao Huang, Xu Liu, Guoqing Zhang, Xiangnan Li

Abstract read
In one paragraph

Article in World journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhulin WangDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Shaowu SunDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Kaiyuan LiDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Chunyao HuangDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Xu LiuDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.
Guoqing ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China. drzhangguoqing@163.com.
Xiangnan LiDepartment of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China. lxn-2000@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased. The purpose of this study was to explore the feasibility of combined surgery for esophageal cancer by analyzing the occurrence of postoperative complications in patients with esophageal cancer.

methodsThe clinical characteristics of 1566 patients with esophageal cancer who underwent thoracic surgery in our hospital between January 2017 and September 2022 were analyzed retrospectively. The feasibility of combined surgery for esophageal cancer was analyzed by comparing postoperative complications in patients who underwent simple esophageal cancer surgery (SEC) with those in patients who underwent combined surgery for esophageal cancer (COEC). The tendency scores of patients in the COEC and SEC groups (1:2) were matched to balance the confounding clinical factors, and the difference in postoperative complications was further analyzed. Moreover, we performed a subgroup analysis of esophagectomy combined with lung resection (ECL). In addition, the independent risk factors for postoperative Clavien-Dindo ≥ grade III complications of esophageal cancer were analyzed by multivariate logistic regression.

resultsA total of 1566 patients (1147 (73.2%) males and 419 (26.8%) females), with an average age of 64.2 years, were analyzed. There was no significant difference in postoperative complications between the SEC and COEC groups according to the Clavien-Dindo classification (P=0.713). An analysis of the complications revealed that those in the COEC group had a higher incidence of lung consolidation than those in the SEC group (P=0.007). However, when we performed propensity score matching (PSM) on the SEC and COEC groups, there was still no significant difference in complications according to the Clavien-Dindo classification (P=0.346); furthermore, when a detailed analysis of complications was performed, there was no significant difference between the two. In subgroup analysis, after we performed PSM in ECL patients and SEC patients, we also found no significant difference in postoperative complications between patients with ECL and patients with SEC. In addition, we found that a history of diabetes (OR=1.604, P=0.029, 95% CI=1.049-2.454), a history of coronary heart disease (OR=1.592, P=0.046, 95% CI=1.008-2.515), diffusing capacity of the lungs for carbon monoxide (DLCO) (OR=0.916, P=0.024, 95% CI=0.849-0.988), and ALB level (OR=0.955, P=0.007, 95% CI=0.924-0.987) were independent factors that influenced postoperative complications in esophageal cancer patients with grade III or higher complications.

conclusionCombined surgery for esophageal cancer does not increase the incidence of postoperative complications. In addition, a history of diabetes mellitus or coronary heart disease, carbon monoxide dispersion, and preoperative ALB level are independent risk factors for grade III or higher postoperative complications of esophageal cancer.

Indexed as

Carbon MonoxideEsophageal NeoplasmsEsophagectomyFeasibility StudiesFemaleHumansMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesCarbon MonoxideAnastomotic leakageCombined surgeryEsophageal cancerPostoperative complicationsPSM

Identifiers

PMID36765428
PMCPMC9912580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.